Newcells Biotech (“Newcells”), a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes,…
Read updateHow do you envision the role of AI evolving in the drug discovery process over the next decade? Colin Brown: “The role of AI in the discovery…
Read updateNewcells Biotech Limited, a team of internationally recognised experts in the building and application of complex models of human tissues for drug discovery, was awarded £1m to deliver their…
Read updateWhat are the latest trends for new in vitro models? There are really two trends. The first one, of course, is to make more physiologically…
Read updateWhat are the latest trends for new in vitro models? In the field, we have been talking about very complex models, so-called organs on chip,…
Read updateNewcastle, UK, 09 September 2024: Newcells Biotech (“Newcells”), a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction…
Read updateWhat are the latest trends for new in vitro models ? I think the latest trend that we are seeing is in terms of the ability of…
Read updateNewcells Biotech (“Newcells”), a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes,…
Read updateA Unique Exhibition-Poster Integration One striking feature of JSOT is how they seamlessly integrate exhibitions with poster sessions. Exhibitors and poster presenters are…
Read updateNewcells Biotech (“Newcells”), a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes,…
Read updateHow does Newcells works with their clients? Listen to our CEO, Dr Mike Nicholds explaining. Webinar on demand: Moving compounds to IND using predictive retinal models. Our panel of experts…
Read updateDr Valeria Chichagova appointed as Director of Technology, Dr Colin Brown as Chief Scientific Officer, and Professor Lyle Armstrong as Scientific Advisor New US commercial appointments also announced…
Read update